CSIMarket

Model N Inc.  (MODN)
Other Ticker:  
 
 
Price: $33.2100 $-0.56 -1.658%
Day's High: $33.6573 Week Perf: 4.3 %
Day's Low: $ 32.38 30 Day Perf: 13.69 %
Volume (M): 126 52 Wk High: $ 37.25
Volume (M$): $ 4,198 52 Wk Avg: $27.80
Open: $33.49 52 Wk Low: $20.95



 Market Capitalization (Millions $) 1,227
 Shares Outstanding (Millions) 37
 Employees 864
 Revenues (TTM) (Millions $) 212
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 24
 Capital Exp. (TTM) (Millions $) 1

Model N Inc.

Model N is a leader in Revenue Management solutions. Our solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, we support the complex business needs of the world’s leading brands in life sciences and technology across tens of thousands of users located in more than 100 countries. A representative list of our customers from life sciences and technology includes AstraZeneca, Boston Scientific, Johnson & Johnson, Microchip Technology and Novartis.

Many companies, in particular in the life sciences and technology industries, experience a gap between the strategic importance of revenue management and the current state of their revenue management processes. Historically, companies tended to rely on a disjointed patchwork of manual processes, spreadsheets, point applications and legacy systems to manage their revenue processes. These processes and systems operated in isolation from one another and were labor intensive, error prone, inflexible and costly, often resulting in missed revenue opportunities, suboptimal margins and increased revenue compliance risk. Current industry trends, which include shortening product lifecycles, tightening compliance and regulatory controls, increasing channel complexity and growing volumes of transactional data are causing these outdated processes and legacy systems to become increasingly ineffective.

Our expertise in cloud-based revenue management solutions and knowledge of the life sciences and technology industries has enabled us to develop software designed to meet the unique, strategic needs of these industries, such as managed care and government pricing for life sciences companies and channel incentives for technology companies. Our solutions are also applicable to companies in industries that sell complicated configurations of products such as in manufacturing. Model N Revenue Cloud transforms the revenue lifecycle into a strategic, end-to-end process aligned across the enterprise. Our industry specific solution suites – Revenue Cloud for Pharma, Revenue Cloud for Med Tech and Revenue Cloud for High Tech – offer a range of solutions from individual products to complete product suites. Deployments may vary from specific divisions or territories to enterprise-wide implementations. In addition to industry specific clouds, Revenue Cloud provides a broad set of multi-tenant cloud-based products for a variety of industries.

The life sciences and technology industries are large and highly fragmented. Companies in both industries market their products to a global customer base through diverse channels. Significant costs are required to launch a drug to the global market. Regulatory pressures, consolidation, and other factors in these industries continue to drive a significant focus on revenue management.

Management of the revenue lifecycle is a strategic imperative and source of competitive advantage for life sciences and technology companies as they address increasingly globalized markets, sophisticated buyers, complex channels and expanding volumes of data from internal and market sources.

Several trends specific to these industries further complicate revenue management.

Life sciences:

the emergence of large group purchasing, managed care organizations and integrated healthcare delivery networks drive increased pricing pressure, contract volume and complexity;

increased customer and channel incentives and rebates result in the increased risk of extending unearned discounts and the overpayment of rebates;

shift of purchasing influence from physicians to economic buyers makes price and commercial terms key decision making factors;

increased spending on healthcare by governments instead of commercial entities adds further regulatory oversight to transactions; and

increased scope of government mandates, frequency of regulatory reporting and audits, and fines, all of which increase administrative burden and monitoring costs.

Technology:

shortened product lifecycles drive rapid pricing changes and require quick responses to quotes and competitive bidding;

increased number of core technology products sold into different end markets with segment-specific pricing;

cyclicality and rising R&D costs are contributing to a focus on maximizing sell time, margins and revenues;

increased complexity of multi-tiered global distribution channels which intensify channel conflict and price erosion;

changing financial reporting requirements due to channel complexity; and

increased use of off-invoice discounting to offset upfront discounts and mask end-customer pricing result in a lack of price transparency that can erode gross margins.



   Company Address: 777 Mariners Island Boulevard, San Mateo, 94404 CA
   Company Phone Number: 610-4600   Stock Exchange / Ticker: NYSE MODN
   MODN is expected to report next financial results on November 18, 2022.


Customers Net Income grew by MODN's Customers Net Profit Margin grew to

48.48 %

16.52 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
HSTM   -19.41%    
ACN   -36.58%    
AMZN   -32.63%    
CRM   -42.53%    
IBM   -10.59%    
MSFT   -29.05%    
ORCL   -30.15%    
• View Complete Report
   



Cracker Barrel Old Country Store Inc

Cracker Barrel Old Country Store Inc announced a moderate 5.86%, increase in their Sales in the most recent fiscal period

Cracker Barrel Old Country Store Inc delivered mixed results in the most recent fiscal period, where Sales grew by 5.86% to $830.40 millions in comparison to $784.41 millions on a year-over-year basis, while earnings decreased by -4.42 % to $1.47 per share, as comparison at $1.53 in the prior year quarter.

Treasure and Shipwreck Recovery Inc.

Losses Widen but Revenues Unchanged

In the fourth quarter of 2022 earnings season Treasure And Shipwreck Recovery Inc increased losses of $-0.09 per share compared to $-0.02 a year ago and increased losses from $-0.03 per share from the previous quarter.

Nukkleus Inc.

Nukkleus Inc reported third quarter of 2021 earnings season operating deficit of $-1.654491 millions

In the third quarter of 2021 earnings season Nukkleus Inc loss increased of $-0.01 per share compared to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Applied Genetic Technologies Corporation

Losses Widen by Applied Genetic Technologies Corporation in the fourth quarter of 2022 report

In the fourth quarter of 2022 Applied Genetic Technologies Corporation increased losses of $-0.36 per share compared to $-0.29 a year ago and increased losses from $-0.33 per share from the previous quarter.

Us Nuclear Corp.

Us Nuclear Corp announced second quarter of 2022 earnings season operating loss of $-0.271999 millions

In the second quarter of 2022 earnings season Us Nuclear Corp lost money of $-0.01 per share compared to $-0.05 a year ago and from $0.00 per share from the previous quarter.






 

Model N's Segments
 
 
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FSTW's Profile

Stock Price

FSTW's Financials

Business Description

Fundamentals

Charts & Quotes

FSTW's News

Suppliers

FSTW's Competitors

Customers & Markets

Economic Indicators

FSTW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071